Paper41240221
GDF11 Regulates Vascular Smooth Muscle Cell Phenotype Switching to Prevent Aortic Aneurysm Formation.
Su X and 4 others. Cardiovasc Drugs Ther, 2026. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. GDF11 Regulates Vascular Smooth Muscle Cell Phenotype Switching to Prevent Aortic Aneurysm Formation. Papers, record 41240221. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41240221
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- GDF11 Regulates Vascular Smooth Muscle Cell Phenotype Switching to Prevent Aortic Aneurysm Formation.
- PubMed
Topics22
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Muscle, Smooth, Vascular | Major topic |
| Growth Differentiation Factors | Major topic |
| Myocytes, Smooth Muscle | Major topic |
| Aortic Aneurysm, Abdominal | Major topic |
| Bone Morphogenetic Proteins | Major topic |
| Vascular Remodeling | Major topic |
| Animals | |
| Disease Models, Animal | |
| Signal Transduction | |
| Phenotype | |
| Male | |
| Mice, Inbred C57BL | |
| Smad2 Protein | |
| Humans | |
| Smad3 Protein | |
| Mice, Knockout, ApoE | |
| Mice | |
| Angiotensin II | |
| Cells, Cultured | |
| Actins | |
| Transforming Growth Factor beta | |
| Inflammation Mediators |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Y20240108 | Science and Technology Program of Wenzhou | PubMed |
Source PubMed
References33
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30337540 | Abdominal aortic aneurysms. | Nat Rev Dis Primers | 2018 | https://conductscience.org/library/papers/30337540 | PubMed |
| 2 | 33831398 | Abdominal aortic aneurysms. | Prog Cardiovasc Dis | 2021 | https://conductscience.org/library/papers/33831398 | PubMed |
| 3 | 34706173 | Management of Abdominal Aortic Aneurysms. | N Engl J Med | 2021 | https://conductscience.org/library/papers/34706173 | PubMed |
| 4 | 30443031 | Abdominal aortic aneurysm: update on pathogenesis and medical treatments. | Nat Rev Cardiol | 2019 | https://conductscience.org/library/papers/30443031 | PubMed |
| 5 | 37011872 | The role of GDF11 during inflammation - An overview. | Life Sci | 2023 | https://conductscience.org/library/papers/37011872 | PubMed |
| 6 | 38235060 | GDF11 and aging biology - controversies resolved and pending. | J Cardiovasc Aging | 2023 | https://conductscience.org/library/papers/38235060 | PubMed |
| 7 | 40432427 | GDF11 Alleviates Vascular Calcification in VitD3-Overloaded Mice Through Inhibition of Inflammatory NF-κB Signal. | FASEB J | 2025 | https://conductscience.org/library/papers/40432427 | PubMed |
| 8 | 31818357 | Hypoxia-induced miR-1260b regulates vascular smooth muscle cell proliferation by targeting GDF11. | BMB Rep | 2020 | https://conductscience.org/library/papers/31818357 | PubMed |
| 9 | 20101093 | TGF-beta activity protects against inflammatory aortic aneurysm progression and complications in angiotensin II-infused mice. | J Clin Invest | 2010 | https://conductscience.org/library/papers/20101093 | PubMed |
| 10 | 32404506 | ACTRIIA-Fc rebalances activin/GDF versus BMP signaling in pulmonary hypertension. | Sci Transl Med | 2020 | https://conductscience.org/library/papers/32404506 | PubMed |
| 11 | 35461253 | Targeting TGF-β signal transduction for fibrosis and cancer therapy. | Mol Cancer | 2022 | https://conductscience.org/library/papers/35461253 | PubMed |
| 12 | 29848273 | Inflammatory Cells and Proteases in Abdominal Aortic Aneurysm and its Complications. | Curr Drug Targets | 2018 | https://conductscience.org/library/papers/29848273 | PubMed |
| 13 | 10841519 | Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. | J Clin Invest | 2000 | https://conductscience.org/library/papers/10841519 | PubMed |
| 14 | 34459250 | Recombinant Interleukin-19 Suppresses the Formation and Progression of Experimental Abdominal Aortic Aneurysms. | J Am Heart Assoc | 2021 | https://conductscience.org/library/papers/34459250 | PubMed |
| 15 | 23226500 | Efficacy and mechanism of angiotensin II receptor blocker treatment in experimental abdominal aortic aneurysms. | PLoS One | 2012 | https://conductscience.org/library/papers/23226500 | PubMed |
| 16 | 23288157 | Peptide inhibitor of CXCL4-CCL5 heterodimer formation, MKEY, inhibits experimental aortic aneurysm initiation and progression. | Arterioscler Thromb Vasc Biol | 2013 | https://conductscience.org/library/papers/23288157 | PubMed |
| 17 | 37371479 | Pharmacological Inhibition of Gasdermin D Suppresses Angiotensin II-Induced Experimental Abdominal Aortic Aneurysms. | Biomolecules | 2023 | https://conductscience.org/library/papers/37371479 | PubMed |
| 18 | 37660071 | FAM3A reshapes VSMC fate specification in abdominal aortic aneurysm by regulating KLF4 ubiquitination. | Nat Commun | 2023 | https://conductscience.org/library/papers/37660071 | PubMed |
| 19 | 37145254 | Glucagon-Like Peptide-1 Inhibits the Progression of Abdominal Aortic Aneurysm in Mice: The Earlier, the Better. | Cardiovasc Drugs Ther | 2024 | https://conductscience.org/library/papers/37145254 | PubMed |
| 20 | 37392236 | Dexmedetomidine Alleviates Abdominal Aortic Aneurysm by Activating Autophagy Via AMPK/mTOR Pathway. | Cardiovasc Drugs Ther | 2025 | https://conductscience.org/library/papers/37392236 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42752802 | Energetic Decoding of VSMC Plasticity: Metabolic Reprogramming and Phenotypic Switching. | Cardiovasc Drugs Ther | 2026 | https://conductscience.org/library/papers/42752802 | PubMed |
| 42198968 | [Growth differentiation factor 11 attenuates hypoxia/reoxygenation injury in rat H9C2 cardiomyocytes in vitro by inhibiting thioredoxin-1 nitrative inactivation]. | Nan Fang Yi Ke Da Xue Xue Bao | 2026 | https://conductscience.org/library/papers/42198968 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41240221
GET https://conductscience.org/api/papers/v1/41240221/references?page=2